Lluís Escudé

565 total citations
18 papers, 398 citations indexed

About

Lluís Escudé is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lluís Escudé has authored 18 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiation, 12 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lluís Escudé's work include Advanced Radiotherapy Techniques (14 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Prostate Cancer Treatment and Research (6 papers). Lluís Escudé is often cited by papers focused on Advanced Radiotherapy Techniques (14 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Prostate Cancer Treatment and Research (6 papers). Lluís Escudé collaborates with scholars based in Spain, Switzerland and Austria. Lluís Escudé's co-authors include Raymond Miralbell, M. Rouzaud, Meritxell Mollà, A. Hidalgo, Philippe Nouet, S. Jorcano, Youri Popowski, Sergi Sanz, Antony Lomax and Damien C. Weber and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Lluís Escudé

17 papers receiving 390 citations

Peers

Lluís Escudé
José Garcia-Ramirez United States
Subhakar Mutyala United States
R.C. Fogaroli Brazil
Ryoong‐Jin Oh Japan
Xiaodong Wu United States
Naoki Hirasawa Japan
Heming Lu China
M.A. Samuels United States
Nobutaka Mizoguchi Japan
Shuhei Sekii Japan
José Garcia-Ramirez United States
Lluís Escudé
Citations per year, relative to Lluís Escudé Lluís Escudé (= 1×) peers José Garcia-Ramirez

Countries citing papers authored by Lluís Escudé

Since Specialization
Citations

This map shows the geographic impact of Lluís Escudé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluís Escudé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluís Escudé more than expected).

Fields of papers citing papers by Lluís Escudé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lluís Escudé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluís Escudé. The network helps show where Lluís Escudé may publish in the future.

Co-authorship network of co-authors of Lluís Escudé

This figure shows the co-authorship network connecting the top 25 collaborators of Lluís Escudé. A scholar is included among the top collaborators of Lluís Escudé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lluís Escudé. Lluís Escudé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Achard, Vérane, S. Jorcano, M. Rouzaud, et al.. (2019). Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?. Journal of Cancer Research and Clinical Oncology. 145(6). 1581–1588. 3 indexed citations
2.
Rouzaud, M., Wilko F.A.R. Verbakel, M. Björkqvist, et al.. (2018). Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?. Radiation Oncology. 13(1). 114–114. 15 indexed citations
3.
Kountouri, Melpomeni, Thomas Zilli, M. Rouzaud, et al.. (2015). Moderate Hypofractionated Protracted Radiation Therapy and Dose Escalation for Prostate Cancer: Do Dose and Overall Treatment Time Matter?. International Journal of Radiation Oncology*Biology*Physics. 94(2). 272–279. 9 indexed citations
4.
Jornet, N., P. Carrasco, Lluís Escudé, et al.. (2014). Multicentre validation of IMRT pre-treatment verification: Comparison of in-house and external audit. Radiotherapy and Oncology. 112(3). 381–388. 24 indexed citations
5.
Zilli, Thomas, S. Jorcano, M. Rouzaud, et al.. (2010). Twice-Weekly Hypofractionated Intensity-Modulated Radiotherapy for Localized Prostate Cancer With Low-Risk Nodal Involvement: Toxicity and Outcome From a Dose Escalation Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 81(2). 382–389. 20 indexed citations
6.
Rubio, Isabel T., A. Hidalgo, Lluís Escudé, et al.. (2010). Boosting the tumor bed from deep-seated tumors in early-stage breast cancer: A planning study between electron, photon, and proton beams. Radiotherapy and Oncology. 96(2). 192–198. 31 indexed citations
7.
Zilli, Thomas, M. Rouzaud, S. Jorcano, et al.. (2010). Dose Escalation Study with Two Different Hypofractionated Intensity Modulated Radiotherapy Techniques for Localized Prostate Cancer: Acute Toxicity. Technology in Cancer Research & Treatment. 9(3). 263–270. 1 indexed citations
8.
Jorcano, S., Meritxell Mollà, Lluís Escudé, et al.. (2010). Hypofractionated Extracranial Stereotactic Radiotherapy Boost for Gynecologic Tumors: A Promising Alternative to High-Dose Rate Brachytherapy. Technology in Cancer Research & Treatment. 9(5). 509–514. 21 indexed citations
9.
Miralbell, Raymond, Meritxell Mollà, M. Rouzaud, et al.. (2009). Hypofractionated Boost to the Dominant Tumor Region With Intensity Modulated Stereotactic Radiotherapy for Prostate Cancer: A Sequential Dose Escalation Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 78(1). 50–57. 55 indexed citations
10.
Miralbell, Raymond, Damien C. Weber, Javier Elizalde, et al.. (2007). Stereotactic Radiotherapy for Ocular Melanoma: Initial Experience Using Closed Eyes for Ocular Target Immobilization. Technology in Cancer Research & Treatment. 6(5). 413–417. 7 indexed citations
11.
Escudé, Lluís, et al.. (2006). Quality assurance for radiotherapy in prostate cancer: Point dose measurements in intensity modulated fields with large dose gradients. International Journal of Radiation Oncology*Biology*Physics. 66(4). S136–S140. 9 indexed citations
12.
Mollà, Meritxell, Lluís Escudé, Philippe Nouet, et al.. (2005). Fractionated stereotactic radiotherapy boost for gynecologic tumors: An alternative to brachytherapy?. International Journal of Radiation Oncology*Biology*Physics. 62(1). 118–124. 71 indexed citations
13.
Weber, Damien C., Joachim Bogner, Jorn Verwey, et al.. (2005). Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. International Journal of Radiation Oncology*Biology*Physics. 63(2). 373–384. 42 indexed citations
14.
Miralbell, Raymond, et al.. (2004). Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?. International Journal of Radiation Oncology*Biology*Physics. 59(2). 366–371. 20 indexed citations
15.
Miralbell, Raymond, Daniel Taussky, Antony Lomax, et al.. (2003). Influence of rectal volume changes during radiotherapy for prostate cancer: A predictive model for mild-to-moderate late rectal toxicity. International Journal of Radiation Oncology*Biology*Physics. 57(5). 1280–1284. 28 indexed citations
16.
Calvo, Felipe A., et al.. (1990). Intraoperative radiotherapy during lung cancer surgery: Technical description and early clinical results. International Journal of Radiation Oncology*Biology*Physics. 19(1). 103–109. 20 indexed citations
17.
Calvo, Felipe A., Salvador Martín‐Algarra, Ignacio Azinovic, et al.. (1990). Intraoperative Radiotherapy for Recurrent and/or Residual Colorectal Cancer. Medical dosimetry. 15(1). 34–34.
18.
Calvo, Felipe A., et al.. (1989). Intraoperative radiotherapy for recurrent and/or residual colorectal cancer. Radiotherapy and Oncology. 15(2). 133–140. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Garcia-Ramirez Breakdown of academic impact, for papers by Subhakar Mutyala Breakdown of academic impact, for papers by R.C. Fogaroli Breakdown of academic impact, for papers by Ryoong‐Jin Oh Breakdown of academic impact, for papers by Xiaodong Wu Breakdown of academic impact, for papers by Naoki Hirasawa Breakdown of academic impact, for papers by Heming Lu Breakdown of academic impact, for papers by M.A. Samuels Breakdown of academic impact, for papers by Nobutaka Mizoguchi Breakdown of academic impact, for papers by Shuhei Sekii
Rankless by CCL
2026